13F Holdings
中文EN

HTFL Heartflow, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1464521 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY47.4%
TTM net income YoY37.0%
TTM EPS YoY106.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin81.8%
Operating margin-33.1%
Net margin-33.1%
FCF margin-23.5%
EBITDA margin-30.8%

Returns

ROE-29.4%
ROA-22.0%
ROIC (approx.)-58.2%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets20.5%
Debt / equity0.00x
Current ratio4.41x
Interest coverage-4,937.50x

Cash quality & payout

Operating cash flow / net income0.62x
Accruals ratio-8.4%
Payout ratio—
Capex / revenue3.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$72.86M$64.08M$52.59M$49.13M$46.28M$43.42M$37.20M$34.98M
Cost of revenue$11.94M$10.89M$10.42M$10.07M$10.86M$10.65M$9.26M$8.73M
Gross profit$60.92M$53.19M$42.16M$39.06M$35.41M$32.78M$27.94M$26.25M
R&D expense$29.49M$26.26M$21.62M$18.66M$17.30M$15.03M$13.92M$12.28M
SG&A expense$45.28M$44.83M$42.57M$38.15M$33.22M$31.46M$31.52M$30.03M
Operating income-$13.85M-$17.90M-$29.50M-$17.75M-$15.10M-$13.71M-$17.50M-$16.06M
Interest expense$5,000$0$3,000$8,000$3.45M$6.62M$5.09M$5.15M
Pretax income-$11.48M-$15.72M-$27.36M-$24.56M-$50.83M-$9.14M-$32.34M-$32.97M
Income tax$23,000$22,000$23,000-$165,000$30,000$59,000—$5,000
Net income-$11.51M-$15.74M-$27.38M-$24.39M-$50.85M-$9.20M-$32.34M-$32.98M
EBITDA-$12.46M-$16.68M-$28.08M-$16.38M-$13.80M-$12.32M-$16.13M-$14.47M
EPS (basic)-0.13-0.18-0.32—-1.04-1.46-5.25—
EPS (diluted)-0.13-0.18-0.32—-1.04-1.46-5.25—
Weighted avg. shares (diluted)87.25M86.40M85.64M—49.11M6.32M6.16M—
Balance sheet
Cash & equivalents$31.65M$34.36M$19.67M$44.78M$291.17M$80.21M$109.79M$55.84M
Short-term investments$136.09M$128.19M$138.65M$132.01M————
Receivables$48.20M$42.76M$35.53M$29.34M$27.86M$29.69M—$24.64M
Current assets$235.50M$223.97M$211.83M$220.20M$327.79M$118.44M—$82.29M
PP&E, net$10.09M$9.65M$9.83M$8.59M$7.98M$8.07M—$8.92M
Total assets$355.34M$344.46M$344.02M$359.45M$364.40M$159.36M—$118.70M
Current liabilities$53.41M$44.09M$38.02M$42.37M$37.85M$32.94M—$33.60M
Total liabilities$72.80M$64.74M$58.31M$58.80M$109.83M$285.59M—$209.62M
Shareholders' equity$282.54M$279.73M$285.72M$300.65M$254.57M-$894.79M-$889.00M-$859.48M
Shares outstanding87.79M86.72M86.11M85.28M83.47M6.39M—6.12M
Cash flow statement
Operating cash flow$323,000-$8.58M-$30.10M-$10.60M-$2.96M-$27.30M-$13.17M-$14.04M
Capital expenditure$1.40M$1.92M$1.89M$1.90M$1.24M$790,000$1.10M$332,000
Free cash flow-$1.08M-$10.50M-$31.99M-$12.49M-$4.19M-$28.09M-$14.27M-$14.37M
Investing cash flow-$10.45M$21.22M-$1.43M-$235.44M-$1.24M-$790,000-$1.10M-$332,000
Financing cash flow$7.44M$2.05M$6.16M-$50,000$214.94M-$1.77M$72.92M$851,000
Depreciation & amortization$1.39M$1.22M$1.42M$1.37M$1.30M$1.40M$1.37M$1.59M
Stock-based compensation$7.57M$7.91M$6.55M$5.26M$3.96M$2.25M$2.49M$2.51M

Free plan shows the latest 8 periods; Pro shows all 11 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.